A Aralex Aachen research explorer

Libo Sun Sign in to save

OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

0

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (2)

2× Geron Corporation, Parsippany, NJ
1× 7Geron Corporation, Parsippany, NJ

Papers 3 stored

All · Aachen affiliation only

MYF3001: A Randomized Open Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed/Refractory to Janus Kinase Inhibitor
2022 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

2

citations
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase Inhibitor (JAKi)
2021 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

1

citations
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase (JAK) Inhibitor
2020 Blood article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

8

citations

3 results